Search Results 51-60 of 16728 for CLL

  1. Study of a Triple Combination Therapy, DTRM-555, in Patients With R/R CLL or R/R Non-Hodgkin's Lymphomas - Mayo Clinic

    Targeted drug therapies have greatly improved outcomes for patients with relapsed or refractory (R/R) chronic lymphocytic leukemia (CLL) and non-Hodgkin's ...

  2. Rituximab and Bendamustine Hydrochloride, Rituximab and Ibrutinib, or Ibrutinib Alone in Treating Older Patients With Previously Untreated Chronic Lymphocytic Leukemia - Mayo Clinic

    Patients must be diagnosed with CLL in accordance with International Workshop on Chronic Lymphocytic Leukemia (IWCLL) 2008 criteria that includes all of the ...

  3. Pembrolizumab Alone or With Idelalisib or Ibrutinib in Treating Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia or Other Low-Grade B-Cell Non-Hodgkin Lymphomas - Mayo Clinic

    Giving pembrolizumab alone or with idelalisib or ibrutinib may be an effective treatment in patients with chronic lymphocytic leukemia or other low-grade B-cell ...

  4. Pirtobrutinib (oral route) - Mayo Clinic

    For mantle cell lymphoma, chronic lymphocytic leukemia (CLL), and small lymphocytic lymphoma (SLL):. Adults—200 milligrams (mg) once a day. Your doctor may ...

  5. A Study to Define Axl Expression Level in Skin Biopsy Specimens from Patients with Skin Cancer in Relation to Chronic Lymphocytic Leukemia - Mayo Clinic

    The purpose of this study is to define the presence and role of Axl in the risk of skin cancers in patients with CLL as well as non-CLL patients.

  6. Mayo Clinic-Led Researchers Confirm Gene Variants Associated With The Most Common Adult Leukemia

    A national team of researchers led by Mayo Clinic has found that patients with chronic lymphocytic leukemia (CLL) are more likely to have similar DNA ...

  7. Living With Cancer: Chronic lymphocytic leukemia - Mayo Clinic News Network

    Chronic lymphocytic leukemia is a type of cancer of the blood and bone marrow that most commonly affects older adults. Learn about causes, symptoms and ...

  8. Phase 1/2 Study of TP-0903 (an Inhibitor of AXL Kinase) in Patients With Previously Treated CLL - Mayo Clinic

    AXL was identified as a potential therapeutic target in chronic lymphocytic leukemia (CLL). TP 0903 was shown to induce apoptosis in CLL B-cells taken directly ...

  9. Zanubrutinib (oral route) - Mayo Clinic

    This medicine is also used to treat chronic lymphocytic leukemia (CLL) or small lymphocytic lymphoma (SLL). Zanubrutinib is also used in combination with ...

  10. Publications - Curtis A. Hanson, M.D. - Mayo Clinic

    Chronic lymphocytic leukemia (CLL) with Reed-Sternberg-like cells vs Classic Hodgkin lymphoma transformation of CLL: does this distinction matter? Blood ...